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1. Introduction 
In recent years it has been well documented that 
the characteristic increase in plasma phospholipids 
and unesterified cholesterol in patients with chole- 
stasis is the result of the presence of an abnormal lipo- 
protein [ 1-4]. This abnormal lipoprotein has been de- 
signated LP-X. In subsequent s udies information was 
provided with respect to the chemical and physico- 
chemical properties of LP-X and to the structural re- 
lations of the proteins to the lipids in this abnormal 
lipoprotein compound [5-9]. It has also been dem- 
onstrated that the presence of LP-X is exc!usively im- 
ited to patients with cholestasis and obstructive jaun- 
dice [10-12]. However, no experimental data are 
available indicating the site of its formation and the 
mechanisms regulating i s metabolism. In order to 
investigate this problem in detail it is important to 
have an adequate animal model available. In this paper 
we are presenting such a model by the identification 
of LP-X in canine, after surgical ligation of the com- 
mon bile duct. 
2. Material and methods 
2.1. Animals and surgical treatment 
Four healthy beagle dogs ofeither sex (age: 
ranging between 1and 2 years; body weight: ranging 
between 6.5 and 10.5 kg) were fed a commercial dog 
food (Altromen-Trockenfutter; Altrogge, 4937 Lage/ 
Germany) before and after the operation. 
For surgical treatment the dogs were anesthetized 
with Nembutal (Deutsche Abbott GmbH, Ingelheim/ 
Germany) 20 mg/kg body weight. A double ligation 
of the common bile duct was performed uring a 
20-min lasting operation. Postoperatively allanimals 
received lg of Binotal (Bayer AG, Leverkusen) per 
day. 
2.2. Determination o f  LP-X 
The test to determine the presence of LP-X in the 
dogs' serum was performed as previously described 
using a new technique of precipitating lipoproteins in 
gels after electrophoresis with polyanionic ompounds 
[13]. For screening purposes the 'LP-X Rapidophor 
All In' (Immuno AG 1220 Vienna, Industriestrasse 72) 
was used. In addition whole serum and isolated lipo- 
protein fractions were analyzed for its electrophoretic 
behaviour in 1% agarose (Serva, Heidelberg) and 1% 
agar (Difco-Bacto Agar, Detroit Mich.)-gel electro- 
phoresis employing a solution 0.1 molar in MgC12 
containing 0.25% Na-heparin (Serva, Heidelberg), and 
1.3% NaC1. to visualize the lipoproteins after 
electrophoretic separation [ 13]. 
2.3. Immunochemical methods 
Samples of whole serum, intact and partially 
delipidized lipoprotein fractions were studied im- 
munochemicaUy using anti-dog antiserum and anti- 
human albumin antiserum (Behring-Werke, Marburg, 
Lahn/Germany) asantibodies. Immunoelectro- 
phoresis [14] and double diffusion [15] was per- 
formed in 1% agar (Difco-Bacto Agar) employing a 
barbital buffer, pH 8.7, ionic strength 0.05. The 
plates were allowed to develop for 24-36 hr at 37°C. 
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2.4. Chemical analyses 
Esterified and unesterified cholesterol, triglycerides, 
phospholipids and protein were determined as de- 
scribed previously [4]. Sodium, potassium, calcium, 
inorganic phosphorus, glucose, urea, acid, kreatinin, 
total bilirubin, alkaline phosphatase, SGPT and SGOT 
were analyzed employing a Technicon Multicanal 
Autoanalyzer (SMA 12/60; Technicon Instruments 
Corp., Tarrytown, N.Y.) equipped with the standard 
requirements. 
2.5. Isolation and partial delipiclization f LP-X 
LP-X was isolated from dog and human serum 
after its presence was demonstrated by the LP-X 
Rapidophor test. Blood samples were collected, al- 
lowed to clot and the serum was recoverd by low 
speed centrifugation. LP-X was isolated by a previ- 
ously described procedure, which combines heparin 
precipitation, ethanol precipitation and ultracen, 
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Fig. 1. LP-X pattern obtained with the 'Rapidophor All In' 
set for the determination f LP-X in whole serum, c = LP-X 
positive human serum for control; 1 = dog serum before liga- 
tion of the bile duct; 2 = dog serum 8 hr after ligation of the 
bile duct; 3 = dog serum 16hr after ligation of the bile duct; 
4 = dog serum 24 hr after ligation of the bile.duct; 5 = dog 
serum 38 hr after ligation of the bile duct; 6 = dog serum 
72 hr after ligation of the bile duct. 
LP-X fractions was accomplished according to the pro- 
cedure by Gustavson [16]. 
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Fig. 2. Alkaline phosphatase ( -o-e) and alanine aminotransferase (SGPT) (o-o-o) activity, total bilirubin (,-,-*) concentration a d 
result of the LP-X test in canine during a follow-up study after ligation of the common bile duct. ~ Ligation of the blUe duct. 
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a 
Fig. 4. Agarose-electrophoresis pattern: H = isolated LP-X
from humans; D = isolated LP-X from canine. 
b 
Fig. 3. Agar-electrophoresis pattern of.canine control se um 
(1) and isolated LP-X from dog (2); a = Immunoelectro- 
phoresis technique using anti canineserum; b = polyanion 
precipitation technique (0.1 M MgC12 0.25% Na-heparin and 
1.3% NaC1). 
2.6. Eleetronmicroscopy of isolated dog LP-X fraction 
Electronmicroscopy of isolated og LP-X fraction 
was kindly conducted by Dr. Kern, Anatomisches 
Institut, University of Heidelberg, using previously 
described methods [9]. 
3. Results 
In canines it is possible to induce the formation of 
lipoprotein-X after surgical igation of the common 
bile ducts. A f011w-up study of four animals demon- 
strated that this abnormal plasma lipoprotein occurs 
24-30 hr after ligation of the bile duct. From then 
on the plasma concentration f LP-X increases rapid- 
ly with the duration of cholestasis ( ee figs. 1 and 2). 
While sodium, potassium, calcium, inorganic phospho- 
sus, glucose, urea, uric acid, kreatinin remained nor- 
mal during a postoperative p riod of four days, both 
aminotransferases (SGOT, SGPT) total bilirubin and 
alkaline phosphatase howed a marked increase after 
the operation (see fig. 2). 
Chemical and physicochemical fractionaltion of 
canine serum indicated an identical behaviour of ca- 
nine lipoprotein-X in comparison to lipoprotein-X 
from humans [4,6]. LP-X from canines was found to 
be a low density lipoprotein within the density frac- 
tion d 1.006-1.063 g/ml. As LP-X from humans, dog 
LP-X is present in the Cohn-Fraction IV-VI [4] and 
precipitates with Na-heparin and MgC12. It can be 
isolated by a combination of ultracentrifugation, 
heparin-precipitation and Cohn-fractionation [4], a 
procedure preserving the native structure and proper- 
ties of the particle. 
Electron micrographs of isolated canine LP-X re- 
vealed'spherical p rticles with a diameter ranging 
from 300-700 ~,, a strong tendency to aggregate and 
to form rolls, identical to those previously described 
for human LP-X [7,9]. 
The protein lipid composition of canine LP-X 
shows the same unique characteristics a  human LP-X, 
consisting of 5.4% protein, 50% phospholipids, 28% 
cholesterol f which only trace amounts are esterified, 
and 8% triglycerides. It migrates on agar elec'cro- 
phoresis (see figs. 1 and 3) towards the cathode and 
on agarose lectrophoresis towards the anode with a 
mobility slightly less than that of human LP-X (see 
fig. 4). 
Purified LP-X from dog does not react immuno- 
chemically with anti-canine serum. Howercer, after 
partial delipidization the same preparation gave a 
positive reaction not only with anti-canine antiserum, 
Fig. 5. Immunodiffusion pattern of purified intact LP-X from 
dog (1), (2) after partial delipidization against anti-human 
albumin antiserum (3) and anti-canine-antiserum (4). 
55 
Volume 38, number 1. FEBS LETTERS December 1973 
but also with antiserum to human albumin (see fig. 5.). 
This phenomenon has already been described for iso- 
lated LP-X from humans, indicating that albumin 
plays an important role for maintaining the structure 
of LP-X. Furthermore, this experiment demonstrates 
common antigenic determinants of human and dog 
albumin. 
4. Discussion 
Results of the present study indicate that the ab- 
normal ow density lipoprotein (LP-X) characteristic 
for cholestasis n humans can alse be found and iso- 
lated in canines after surgical ligation of the common 
bile duct. The structure as well as the unique physico- 
chemical and chemical properties of human- and ca- 
nine-LP-X are identical. Thus, this animal model 
seems adequate for the study of LP-X metabolism. Of 
particular interest in this respect is the fact, that LP-X 
may now easily be identified in whole serum without 
a specific antiserum using a precipitation technique 
with polyanionic ompounds after electrophoresis on
agar gel [13, 17]. 
Acknowledgement 
The study was supported by grants from the 
Deutsche Forschungsgemeinschaft. 
References 
[1] Russ, E.M., Raymunt, J. and Barr, D.P. (1956) J. Clin. 
Invest. 35, 133. 
[2] Switzer, S. (1967) J. Clin. Invest. 46, 1855. 
[3] Burstein, M. and Caroli, J. (1967) Rev. Franc. Etudes 
Clin. Biol. 12, 898. 
[4] Seidel, D., Alaupovic, P. and Furman, R.H. (1969) 
J. Clin. Invest. 48, 1211. 
[5] Mills, G.L., Seidel, D. and Alaupovic, P. (1969) Clin. 
Chim. Acta 20, 239. 
[6] Seidel, D., Alaupovic, P., Furman, R.H. and McConathy, 
W.J. (1970) J. Clin. Invest. 49, 2396. 
[7] Hamilton, R.L., Havel, R.J., Kane, J.P., Blaurock, A.E. 
and Sata,.T. (1971) 72,475. 
[8] Picard, J., Veissiere, D., Voyer, F. and Bereziat, G. 
(1972) Clin. Chim. Acta 36, 247. 
[9] Seidel, D., Agostini, B. and Muller, P. (1972) Biochim, 
Biophys. Acta 260, 146. 
[10] Seidel, D., Gretz, H. and Ruppert, C.'(1973) Clin. 
Chemistry 19, 86. 
[11] Ritland, S., Blomhoff, J.P., Elgjo, K. and Gjone, E. 
(1973) Scand. J. Gastroenterol. 8,155. 
[12] Poley, J.R., Alaupovic, P., McConathy, W.J., Seidel, D. 
Roy, C.C. and Weber, A. (1973) J. Lab. Clin. Med. 81, 
325. 
[13] Seidel, D., Wieland, H. and Ruppert, C. (1973) Clin. 
Chemistry 19,737. 
[14] Grabar, P. and Williams, C.A. (1955) Biochim. Biophys. 
Acta 17, 67. 
[15] Ouchterlony, O. (1953) Acta Pathol. Microbiol. Scand 
32, 231. 
[16] Gustafson, A. (1965) J. Lipid. Res. 6,512. 
[17] Wieland, H. and Seidel, D. (1973) Eut. Med. Wochschr. 
98, 1474. 
56 
